James C. Morris

Glycerol 3-phosphate alters Trypanosoma brucei hexokinase activity in response to environmental change.

Glycolysis in the african trypanosome: targeting enzymes and their subcellular compartments for therapeutic development.

Extra-glycosomal localisation of Trypanosoma brucei hexokinase 2.

Peptide-targeted delivery of a pH sensor for quantitative measurements of intraglycosomal pH in live Trypanosoma brucei.

Environmentally regulated glycosome protein composition in the African trypanosome.

Interrogating a hexokinase-selected small-molecule library for inhibitors of Plasmodium falciparum hexokinase.

Targeting protozoan parasite metabolism: glycolytic enzymes in the therapeutic crosshairs.

Exploring the mode of action of ebselen in Trypanosoma brucei hexokinase inhibition.

Characterization of an African trypanosome mutant refractory to lectin-induced death.

Identification of Novel Plasmodium falciparum Hexokinase Inhibitors with Antiparasitic Activity.

Evaluation of substituted ebselen derivatives as potential trypanocidal agents.

Antiparasitic lethality of sulfonamidebenzamides in kinetoplastids.

pH regulation in glycosomes of procyclic form .

A targeted delivery strategy for the development of potent trypanocides.

Optimization and Evaluation of Antiparasitic Benzamidobenzoic Acids as Inhibitors of Kinetoplastid Hexokinase 1.

A FRET flow cytometry method for monitoring cytosolic and glycosomal glucose in living kinetoplastid parasites.

Glucose Signaling Is Important for Nutrient Adaptation during Differentiation of Pleomorphic African Trypanosomes.

A Microfluidic-Based Microscopy Platform for Continuous Interrogation of Trypanosoma brucei during Environmental Perturbation.

Enzymatic and Structural Characterization of the Glucokinase.

and human hexokinases share similar active sites but display distinct quaternary architectures.

Dual-Stage Picolinic Acid-Derived Inhibitors of .

Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba.

The transcriptome of Balamuthia mandrillaris trophozoites for structure-guided drug design.

Glucose metabolism in the pathogenic free-living amoebae: Tempting targets for treatment development.

Enolase Inhibitors as Early Lead Therapeutics against .

Synthesis and Evaluation of Benzylamine Inhibitors of Neuropathogenic "Brain-Eating" Amoeba.